Ascendis Pharma A/S ASND
255.55 USD -2.38 (-0.92%)
Nov 5, 2026, 10:41 AM EST
254.33 Day range 257.93
196.01 52-week range 277.18
- YTD
- +19.84%
- 1 year
- +29.23%
Held by funds
132 US ETFs and mutual funds hold ASND · largest positions
Ownership
Held by insiders 0.77%
Held by institutions 103.24%
Float held by institutions 104.04%
Institutions 474
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Massachusetts Financial Services Co. | 0.00% | 1,875,301 | 483.70M | Jun 29, 2026 |
| Blackrock Inc. | 0.00% | 2,211,833 | 570.50M | Jun 29, 2026 |
| Westfield Capital Management Co LP | 0.00% | 4,798,267 | 1.24B | Jun 29, 2026 |
| Capital International Investors | 0.00% | 1,988,614 | 512.92M | Jun 29, 2026 |
| FMR, LLC | 0.00% | 3,545,575 | 914.51M | Jun 29, 2026 |
| Artisan Partners Limited Partnership | 0.00% | 2,634,024 | 679.39M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Franklin Custodian Funds-FRANKLIN DYNATECH FUND | 0.00% | 1,000,000 | 257.93M | Jun 29, 2026 |
| JNL Series Trust-JNL/T. Rowe Price Capital Appreciation Fund | 0.00% | 795,727 | 205.24M | Jun 29, 2026 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 0.00% | 639,106 | 164.84M | Jun 29, 2026 |
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 0.00% | 3,364,767 | 867.87M | Jun 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 0.00% | 1,099,854 | 283.69M | Jul 30, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 0.00% | 500,000 | 128.96M | Aug 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BIENAIME JEAN-JACQUES | Director | Purchase | Aug 13, 2026 | 2,900 |
| BODENHOFF MADS | Officer | Sale | Sep 7, 2026 | 0 |
| HOLTUG LARS | Director | Sale | Sep 1, 2026 | 4,000 |
| JENSEN FLEMMING STEEN | Officer | Sale | May 10, 2026 | 0 |
| SMITH SCOTT THOMAS | Chief Financial Officer | Purchase | Jun 1, 2026 | 4,367 |